Xylazine-Associated Wounds: Considerations for Antimicrobial Stewardship and Wound Care

Jan. 2025Important Notices

Please join us for a live, CME-accredited webinar on Tuesday, Feb. 25, from noon to 1 p.m. that will educate providers on the important topic of xylazine associated wounds.

At the end of this learning session, you will be able to:

  • Discuss antimicrobial stewardship program adaptations for people who inject drugs.
  • Identify outpatient antimicrobial treatment considerations for xylazine-associated wounds.
  • Review pharmacology and treatment of xylazine toxicity and withdrawal.

Presenters:

    • Michael Lynch, MD, FACMT, UPMC Health Plan Quality and Substance Use Disorder Services Senior Medical Director; Director, UPMC Medical Toxicology Telemedicine Bridge Clinic; Associate Professor, Division of Medical Toxicology, Department of Emergency Medicine, University of Pittsburgh School of Medicine

Amanda Hoyer, MPH,

    Epidemiology Research Associate, Division of Healthcare Associated Infection Prevention, Bureau of Epidemiology, Pennsylvania Department of Health

Register now. This webinar will be recorded.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team. The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Provider is responsible for verifying CME eligibility.

Recent Announcements

PA DOH Antibiotic Stewardship Resources

Order antibiotic stewardship resources at no cost
Jun. 2026Important Notices

Medical device correction: Omnipod (Insulet – May 2026)

Insulet Corporation Inc. has announced a medical device correction for certain Omnipod Pods. These pods are wearable devices that are used to deliver insulin.
Jun. 2026Pharmacy Updates

Clinical documentation required for medical policy prior authorizations

As you know, UPMC Health Plan requires certain clinical documentation/notes in support of a request for prior authorization for the listed procedures below in accordance with its established policies and procedures, in addition to CMS requirements that medical record documentation must support the medical necessity of the services requested.
Jun. 2026Important Notices